• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Concentra Appoints Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer

    11/10/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care
    Get the next $CON alert in real time by email

    Concentra®, (NYSE:CON) the nation's largest provider of occupational health services, today announced the appointment of Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer. In this role, he will ensure Concentra's data strategy and governance, technology enablement, and insight generation are aligned with enterprise growth priorities.

    "Selecting Jason as our Chief Data, Analytics, and Artificial Intelligence Officer represents the natural progression of Concentra's established foundation in data, technology, and innovation," said Keith Newton, Chief Executive Officer of Concentra. "His expertise and extensive experience will enable us to continue to operationalize data, optimize enterprise-wide analytics, and accelerate AI adoption."

    An experienced senior leader with over 25 years of experience leveraging data and technology, Cooper excels in driving significant business outcomes across private, for-profit, and nonprofit sectors. His experience includes roles serving L3-Communications, MATRIC, CVS Caremark, Cigna, Blue Cross Blue Shield plans, consulting with VC-and PE-backed firms, and most recently HMS and Paradigm Corp.

    "Concentra has always had a notable focus on data-driven outcomes, data governance, and digital connectivity," said Cooper. "I am excited to help build upon its significant background as an innovator and industry leader by championing the organization's data, analytics, and artificial intelligence efforts."

    Cooper is an active member of the Society for Information Management and a Fellow of the American College of Health Data Management. He also serves on the board of directors for Covenant HR and as an advisor to .406 Ventures' Data and AI executive council.

    About Concentra

    Concentra is the largest provider of occupational health services in the United States by number of locations, with the mission of improving the health of America's workforce, one patient at a time. Our 13,000 colleagues and affiliated physicians and clinicians support the delivery of an extensive suite of services, including occupational and consumer health services and other direct-to-employer care, to more than 50,000 patients each day on average from 628 occupational health centers and 413 onsite health clinics at employer worksites in 47 states as of September 30, 2025. www.Concentra.com

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251110381610/en/

    Anna Kleiner

    214-596-8735

    [email protected]

    Get the next $CON alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CON

    DatePrice TargetRatingAnalyst
    9/18/2025$31.00Overweight
    Analyst
    12/16/2024$24.00Neutral → Buy
    BofA Securities
    10/7/2024$30.50 → $24.00Buy → Neutral
    BofA Securities
    8/20/2024$33.00Outperform
    RBC Capital Mkts
    8/19/2024Buy
    BofA Securities
    8/19/2024$29.00Buy
    Deutsche Bank
    8/19/2024$29.00Overweight
    JP Morgan
    8/19/2024$32.00Buy
    Goldman
    More analyst ratings

    $CON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on Concentra with a new price target

    Analyst resumed coverage of Concentra with a rating of Overweight and set a new price target of $31.00

    9/18/25 8:38:55 AM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent upgraded by BofA Securities with a new price target

    BofA Securities upgraded Concentra Group Holdings Parent from Neutral to Buy and set a new price target of $24.00

    12/16/24 6:50:31 AM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent downgraded by BofA Securities with a new price target

    BofA Securities downgraded Concentra Group Holdings Parent from Buy to Neutral and set a new price target of $24.00 from $30.50 previously

    10/7/24 7:46:54 AM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Concentra Appoints Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer

    Concentra®, (NYSE:CON) the nation's largest provider of occupational health services, today announced the appointment of Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer. In this role, he will ensure Concentra's data strategy and governance, technology enablement, and insight generation are aligned with enterprise growth priorities. "Selecting Jason as our Chief Data, Analytics, and Artificial Intelligence Officer represents the natural progression of Concentra's established foundation in data, technology, and innovation," said Keith Newton, Chief Executive Officer of Concentra. "His expertise and extensive experience will enable us to continue to operationalize

    11/10/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent, Inc. Announces Results For Its Third Quarter Ended September 30, 2025, Cash Dividend, and Raised FY 2025 Guidance

    Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced results for its third quarter ended September 30, 2025, the declaration of a cash dividend, and raised guidance for full year 2025. "2025 has continued to be an excellent year for Concentra," said Keith Newton, Chief Executive Officer of Concentra. "Building on our business growth in the first half of the year, our strong third quarter results delivered year-over-year increases in revenue, net income, and Adjusted EBITDA driven by visit and rate growth, as well as executing on our inorganic strategy. Our stellar

    11/6/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra® to Announce Third Quarter 2025 Results on Thursday, November 6, 2025

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its third quarter ended September 30, 2025, on Thursday, November 6, 2025, after the market closes. Concentra will host a conference call regarding its financial results on Friday, November 7, 2025, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's investor relations website. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free:

    10/6/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    SEC Filings

    View All

    Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Leadership Update

    8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)

    11/10/25 5:00:38 PM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form 10-Q filed by Concentra Group Holdings Parent Inc.

    10-Q - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)

    11/6/25 5:02:20 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)

    11/6/25 4:40:09 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Rhine Michael D. was granted 40,000 shares, increasing direct ownership by 100% to 80,098 units (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    11/6/25 5:32:42 PM ET
    $CON
    Medical Specialities
    Health Care

    Officer Kosuth Michael A. was granted 60,000 shares, increasing direct ownership by 100% to 120,000 units (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    11/6/25 5:31:33 PM ET
    $CON
    Medical Specialities
    Health Care

    Officer Dicanio Matthew T. was granted 180,000 shares, increasing direct ownership by 100% to 360,000 units (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    11/6/25 5:30:31 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Leadership Updates

    Live Leadership Updates

    View All

    Concentra Appoints Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer

    Concentra®, (NYSE:CON) the nation's largest provider of occupational health services, today announced the appointment of Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer. In this role, he will ensure Concentra's data strategy and governance, technology enablement, and insight generation are aligned with enterprise growth priorities. "Selecting Jason as our Chief Data, Analytics, and Artificial Intelligence Officer represents the natural progression of Concentra's established foundation in data, technology, and innovation," said Keith Newton, Chief Executive Officer of Concentra. "His expertise and extensive experience will enable us to continue to operationalize

    11/10/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Announces the Appointment Of Vipin Gopal and Brigid Bonner To Its Board Of Directors

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON), today announced the appointment of Vipin Gopal and Brigid Bonner to the Concentra Board of Directors, marking a strategic milestone for the occupational health services company. "We are pleased to welcome Vipin Gopal and Brigid Bonner to the Concentra Board," said Bob Ortenzio, Concentra's board chair. "As Concentra navigates growth and the opportunity to increase shareholder value, expanding the Board with two prominent health care leaders with data, technology, and business transformation expertise will prove to be a mobilizing force for the company." Vipin Gopal, PhD, brings over 25 years of experience successfully lead

    6/26/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

    NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin

    11/19/24 5:56:00 PM ET
    $AZTA
    $CON
    $ENV
    Industrial Machinery/Components
    Technology
    Medical Specialities
    Health Care

    $CON
    Financials

    Live finance-specific insights

    View All

    Concentra® to Announce Third Quarter 2025 Results on Thursday, November 6, 2025

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its third quarter ended September 30, 2025, on Thursday, November 6, 2025, after the market closes. Concentra will host a conference call regarding its financial results on Friday, November 7, 2025, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's investor relations website. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free:

    10/6/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent, Inc. Announces Results For Its Second Quarter Ended June 30, 2025, Cash Dividend, and Raised FY 2025 Guidance

    Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced results for its second quarter ended June 30, 2025, the declaration of a cash dividend, and raised guidance for FY 2025. "Concentra delivered strong results in the second quarter, building on our solid start to 2025," said Keith Newton, Chief Executive Officer of Concentra. "Our results reflected strength across several key measures, including growth in patient visits, rate, revenue, and Adjusted EBITDA. We are well-positioned for continued momentum driven by the disciplined execution of our strategy by our outs

    8/7/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra® to Announce Second Quarter 2025 Results on Thursday, August 7, 2025

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its second quarter ended June 30, 2025, on Thursday, August 7, 2025, after the market closes. Concentra will host a conference call regarding its financial results on Friday, August 8, 2025, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free:

    7/7/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

    SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/9/24 6:02:26 AM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

    SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/6/24 4:32:57 PM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form SC 13D filed by Concentra Group Holdings Parent Inc.

    SC 13D - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/3/24 4:21:17 PM ET
    $CON
    Medical Specialities
    Health Care